Ask questions and gain insights about this stock now with Rize AI
CVS logo

CVS Health Corporation

CVS

Stock Analysis

$68.49

+0.00 (+0.00%)• Live

CVS Health Corporation Analysis Dashboard - Stock Analysis and Financial Metrics

Historical Prices

for CVS Health Corporation

Key Financial Metrics

for CVS Health Corporation

2024 FY
P/E Ratio
15.70
Revenue Growth
+4.20%
EPS Growth
-43.61%
Market Cap
$83.14B
Dividend Yield
+4.05%
Debt/Equity
1.06
ROIC
+4.03%
FCF Yield
+7.15%
View additional metrics

Valuation

P/B Ratio1.08
EV/Sales0.41

Financial Health

Current Ratio0.82
Return on Assets+3.83%

Analyst Recommendations

for CVS Health Corporation

41 analysts
Consensus: Buy

About

for CVS Health Corporation

Company Details

for CVS Health Corporation

Sector

Healthcare

Industry

Medical - Healthcare Plans

CEO

J. David Joyner CEBS

Employees

219,000

Market Cap

86.64B

Exchange

New York Stock Exchange

IPO Date

November 20, 1996

CIK

0000064803

ISIN

US1266501006

CUSIP

126650100

Country

US

Balance Sheet

for CVS Health Corporation

Cash Flow Statement

for CVS Health Corporation

Income Statement

for CVS Health Corporation

Rize ist ein KI-gestütztes Investment-Research-Terminal, das eine umfassende Aktienanalyse und Einblicke über ein intuitives Dashboard bietet.

News

No news available at the moment.